Verma Drugs S.A.

We are thrilled to announce that Verma Drugs S.A. Drugs is entering a strategic partnership with leading academic institutions and renowned Greek universities! Together, we will drive forward innovative development in breakthrough treatments for #Oncology and #Alzheimer’s disease. Through this collaboration, we aim to bridge cutting-edge scientific research with real-world application, accelerating advancements that bring us closer to transformative solutions in these critical areas. By synergizing our expertise, we’re committed to making a lasting impact on the lives of patients and their families worldwide. This partnership underscores our dedication to pushing the boundaries of what’s possible in medicine. We’re proud to work alongside such esteemed academic institutions to pave the way for a healthier future. Stay tuned for more updates as we embark on this journey together! #VermaDrugs #InnovationInHealth #AcademicPartnership #Oncology #AlzheimersResearch #BreakthroughsInMedicine #GlobalHealth

We are thrilled to announce that Verma Drugs S.A. Drugs is entering a strategic partnership with leading academic institutions and renowned Greek universities! Together, we will drive forward innovative development in breakthrough treatments for #Oncology and #Alzheimer’s disease. Through this collaboration, we aim to bridge cutting-edge scientific research with real-world application, accelerating advancements that bring us closer to transformative solutions in these critical areas. By synergizing our expertise, we’re committed to making a lasting impact on the lives of patients and their families worldwide. This partnership underscores our dedication to pushing the boundaries of what’s possible in medicine. We’re proud to work alongside such esteemed academic institutions to pave the way for a healthier future. Stay tuned for more updates as we embark on this journey together! #VermaDrugs #InnovationInHealth #AcademicPartnership #Oncology #AlzheimersResearch #BreakthroughsInMedicine #GlobalHealth

We are thrilled to announce our participation in the upcoming MEDICA - Leading International Trade Fair in Düsseldorf, Germany, from November 13-14. This prestigious event is a key platform for innovation and collaboration in the healthcare industry. Our Vice President, teresa gamvrouli, and our Head of Strategy, Marianna Anastasakou, will be representing Verma Drugs S.A., showcasing our commitment to advancing healthcare solutions. At Verma Drugs, we are proud to offer a diverse range of products designed to enhance patient care and treatment outcomes, including: - Dialysis Solutions Compatible with All Dialysis Machines - The VermaClean Series provides a comprehensive solution for the easy cleaning and disinfection of the fluid paths in dialysis machines. -Sodium Bicarbonate Cartridges & Bags: Essential components for effective dialysis treatment.  -New PD VermaCap: Featuring povidone-iodine, this innovation ensures easy connection and disconnection, minimizing the risk of peritonitis and allowing safe session interruption during emergencies in PD.   -Global Presence in OEM Solutions: We specialize in manufacturing products tailored to your specifications and providing finished, pre-designed products under your brand name for hemodialysis. Join us at MEDICA - Leading International Trade Fair to explore how Verma Drugs S.A. is transforming healthcare and to connect with our team to discuss potential collaborations. We’re eager to explore potential collaborations in the renal sector. If you’re attending the conference and would like to discuss partnerships or share insights, please reach out to schedule a meeting at info@verma.gr. We look forward to seeing you there! #VermaDrugs #MEDICA2024 #HealthcareInnovation #Dialysis #PatientCare #OEMSolutions #Düsseldorf

We are delighted to share the official launch of the new Verma Drugs S.A. website. This new platform is not just an upgrade, it represents our strategic commitment to innovation and excellence in the medical technology field. At Verma Drugs S.A., we prioritize innovation as the cornerstone of our philosophy, and our revamped website showcases our dedication to developing advanced medical solutions that enhance patient care. We invite you to explore the new website and discover its enhanced features. Thank you for your ongoing support on this exciting journey! https://verma.gr/

We’re pleased to share that Verma Drugs S.A. will be participating in the CPHI annual conference in Milan from October 9-10. CPHI is renowned for its role in connecting the global pharma community and inspiring impactful partnerships that drive industry innovation. This year’s event promises to be a premier platform for networking and discovering the latest advancements in the pharmaceutical sector. Our delegation—teresa gamvrouli, Vice President; Konstantinos Karapas, Production Manager; and Marianna Anastasakou, Head of Strategy—will be representing Verma Drugs S.A. Our objective is to engage with industry leaders, explore new collaboration opportunities, and further our mission of advancing innovation in renal pharmaceuticals. We look forward to discussing how we can work together to tackle the challenges and seize the opportunities within the renal pharmaceutical field. If you’re attending the conference and are interested in potential partnerships or a meaningful exchange, please schedule a meeting at info@verma.gr. See you in Milan!

Verma Drugs S.A. and our private renal clinic, Polyxenia (www.polyxenia-renal.gr), are honoured to sponsor Maria Fragou and the "ATLANTAS" Kidney Patients and Transplants Sports Association at the upcoming World Transplant Games Federation The European Transplant Sports Championships, first staged in Athens in 2000, are held every two years in different countries. This prestigious event features a week of multi-sport competition among solid organ #transplant recipients, people on #dialysis, and #hematopoietic cell transplant recipients from over 25 European countries. For the first time in history, two federations will unite: the European Heart and Lung Transplant Federation and the European Transplant & Dialysis Sports Federation. This partnership will promote the immense benefits of organ donation and the incredible life-saving impact of organ transplants. The event will be hosted by GDTP – Grupo Desportivo de Transplantados de Portugal alongside O-Sports. Our commitment to improving patient lives extends beyond medication, it's about empowering individuals to achieve their dreams despite medical challenges. Maria's journey epitomizes resilience and the extraordinary potential of kidney patients. By supporting her and the ATLANTAS team, we stand by all patients and celebrate their incredible strength and determination. Join us in cheering for Maria and all the inspiring participants at the Games! #PatientSupport #KidneyTransplants #PanEuropeanGames #VermaDrugs #Lisbon2024 #OrganDonation #TransplantSports

We are thrilled to unveil our new promotional material that signifies a bold step forward in our commitment to innovation and excellence in the healthcare industry. This new design is more than just an update – it is a reflection of our core values and our mission to improve lives through groundbreaking research and personalized medicine. The new artwork features a vibrant DNA strand, symbolizing our dedication to advancing genomic medicine and personalized healthcare solutions. At Verma Drugs, we believe that true innovation stems from understanding and harnessing the power of genetics to create tailored treatments that meet the unique needs of each patient. Our focus on genomic medicine and personalized treatment plans ensures that we are not just keeping up with advancements but leading the way in developing cutting-edge therapies. This patient-centric approach drives everything we do, aiming to improve patient outcomes and enhance quality of life. Our commitment to staying at the forefront of global trends in healthcare means actively participating in partnerships and collaborations that drive progress in the sector. We believe in the power of teamwork and are dedicated to working alongside other industry leaders to bring about significant improvements in patient care. Our new promotional material serves as a reminder of this commitment and our continuous efforts to place patients at the centre of our innovations. We invite all our employees, partners, and industry peers to embrace this new era with us. Together, we can achieve remarkable milestones in the world of healthcare, one discovery at a time. #Innovation #Healthcare #Pharmaceuticals #GenomicMedicine #PersonalizedHealthcare #VermaDrugs #ResearchAndDevelopment #PatientCare #HealthcareInnovation

At Verma Drugs, we are committed to maintaining a workplace where all employees have the opportunity to maximize their performance as a team. Our people are our true source of growth and innovation! We attract and retain candidates who share high levels of expertise and know-how, and go through a series of competency-based interviews and assessment tests aligned with our fundamental corporate values: Integrity, Innovation, Achievement Orientation, Customer Service Orientation, Leadership, Teamwork, Change Management, and Initiative. Being a leader in the renal market makes us even more committed to the development of our people. Our employees are the driving force behind our success and our key priority is to maintain a working environment where all employees are constantly aware of their contribution to the company’s objectives. We encourage all employees to participate in their career development plans and help them keep track of their performance through continuous feedback. We also invest in training & development programs. Join us in celebrating the people who make Verma Drugs a success! #TeamVermaDrugs #EmployeeDevelopment #WorkplaceExcellence #Innovation #Leadership #Teamwork

We are thrilled to share some wonderful news! Verma Drugs has been honoured by the Hellenic Nephrology Association of Nurses (ENEN) for our continuous support and contribution to the renal patient society. This recognition was awarded during the 15th Panhellenic Conference of Nephrology Nurses, which took place in Nafpaktos. We are deeply grateful for this honour and are committed to continuing our support for the education and professional development of nephrology nurses. Our partnership with ENEN reflects our dedication to improving patient healthcare and supporting the continuous education of healthcare professionals. Thank you to the Hellenic Nephrology Association of Nurses for this recognition. We look forward to our ongoing collaboration and the positive impact we can achieve together to improve patient lives.

At Verma Drugs, our dedication to improving kidney health continues. We were excited to share our insights and breakthroughs at the forefront of kidney disease treatment and management. This year's congress theme, "Rethinking Kidney Health and Transforming Kidney Care," resonates deeply with our mission. We are committed to pushing the boundaries of what's possible in clinical practice and patient care. Dr. Griveas Ioannis delivered an insightful presentation on the innovative use of Citric Acid Blood Purification Solution combined with L-Ascorbic Acid (Vitamin C) for hemodialysis patients. Dr. Griveas's presentation highlighted the pioneering integration of acidic citrate and L-Ascorbate, known as CitraVit, which significantly mitigates oxidative stress and chronic inflammation during dialysis. CitraVit ensures the preservation of vital Vitamin-C levels, improves clinical outcomes, and promotes consistent hemodynamic stability, all while adhering to the rigorous standards of the European Pharmacopoeia. Thank you to everyone who attended and contributed to the success of this year's ERA Congress! #ERACongress #KidneyHealth #RenalCare #VermaDrugs #Innovation #ClinicalPractice #Hemodialysis #CitraVit